Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $31.4950 (2.62%) ($29.5000 - $32.0800) on Tue. Sep. 8, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.15% (three month average) | RSI | 63 | Latest Price | $31.4950(2.62%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -1.1% a day on average for past five trading days. | Weekly Trend | IOVA advances 5.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(48%) XBI(45%) ARKG(44%) IWO(42%) ARKK(40%) | Factors Impacting IOVA price | IOVA will decline at least -1.575% in a week (0% probabilities). VIXM(-23%) UUP(-16%) VXX(-12%) TBT(-6%) UNG(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.575% (StdDev 3.15%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $32.08(-1.82%) | 10 Day Moving Average | $31.19(0.98%) | 20 Day Moving Average | $30(4.98%) | To recent high | -7.1% | To recent low | 15.7% | Market Cap | $4.612b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |